These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38820490)

  • 1. Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B.
    Gao M; Chen L; Yang J; Dong S; Cao Q; Cui Z; Dong Y; Liu H; Shen Y; Yang H; Hao Z; Zhang L; Li W; Tie JK; Shen G
    Blood Adv; 2024 Aug; 8(15):3893-3905. PubMed ID: 38820490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay.
    Gao W; Xu Y; Liu H; Gao M; Cao Q; Wang Y; Cui L; Huang R; Shen Y; Li S; Yang H; Chen Y; Li C; Yu H; Li W; Shen G
    Blood Adv; 2020 Aug; 4(15):3659-3667. PubMed ID: 32766856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular Basis of FIX Deficiency in Hemophilia B.
    Shen G; Gao M; Cao Q; Li W
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
    Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
    Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.
    Lu L; Wang L; Shen W; Fang S; Zhao L; Hu X; Yang L; Wang G
    Mol Genet Genomic Med; 2023 May; 11(5):e2147. PubMed ID: 36795372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.
    Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation.
    Pignani S; Todaro A; Ferrarese M; Marchi S; Lombardi S; Balestra D; Pinton P; Bernardi F; Pinotti M; Branchini A
    J Thromb Haemost; 2018 Oct; 16(10):2035-2043. PubMed ID: 29993188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B.
    Ferrarese M; Testa MF; Balestra D; Bernardi F; Pinotti M; Branchini A
    Hum Mutat; 2018 May; 39(5):702-708. PubMed ID: 29388273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.
    Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F
    Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors.
    Shu M; Malcolmson C; Bosch A; Markovic T; Wakefield C; Bouskill V; Carcao M
    Haemophilia; 2024 Jul; 30(4):1003-1009. PubMed ID: 38924261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of inherited protein C deficiency results from genetic variations in the signal peptide and propeptide regions.
    Cao Q; Hao Z; Li C; Chen X; Gao M; Jiang N; Liu H; Shen Y; Yang H; Zhang S; Yang A; Li W; Tie JK; Shen G
    J Thromb Haemost; 2023 Nov; 21(11):3124-3137. PubMed ID: 37393002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations.
    Lin PC; Su YN; Liao YM; Chang TT; Tsai SP; Shu HL; Chiou SS
    Kaohsiung J Med Sci; 2014 Apr; 30(4):187-93. PubMed ID: 24656159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations.
    Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation.
    Zhang H; Xin M; Lin L; Chen C; Balestra D; Ding Q
    J Thromb Haemost; 2024 Apr; 22(4):975-989. PubMed ID: 38184202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B.
    Shah J; Kim H; Sivamurthy K; Monahan PE; Fries M
    Curr Med Res Opin; 2023 Feb; 39(2):227-237. PubMed ID: 36285399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.
    Branchini A; Morfini M; Lunghi B; Belvini D; Radossi P; Bury L; Serino ML; Giordano P; Cultrera D; Molinari AC; Napolitano M; Bigagli E; Castaman G; Pinotti M; Bernardi F;
    J Thromb Haemost; 2022 Jan; 20(1):69-81. PubMed ID: 34626083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of hemophilia B patients in Colombia.
    Parrado Jara YA; Yunis Hazbun LK; Linares A; Yunis Londoño JJ
    Mol Genet Genomic Med; 2020 May; 8(5):e1210. PubMed ID: 32155688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.